Royal Fund Management, LLC Moderna, Inc. Transaction History

Royal Fund Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 11, 2024	SELL	$85.37 - $115.44 $119,518 - $161,616	-1,400 Reduced 15.48%	7,645 $814,000
Q4 2023 Feb 06, 2024	SELL	$69.51 - $104.43 $187,677 - $281,961	-2,700 Reduced 22.99%	9,045 $899,000
Q3 2023 Oct 17, 2023	BUY	$96.41 - $126.61 $375,999 - $493,779	3,900 Added 49.71%	11,745 $1.21 Million
Q2 2023 Jul 12, 2023	BUY	$118.5 - $160.53 $393,420 - $532,959	3,320 Added 73.37%	7,845 $953,000
Q1 2023 Apr 10, 2023	BUY	$135.66 - $197.02 $613,861 - $891,515	4,525 New	4,525 $694,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Royal Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Royal Fund Management, LLC with notifications on news.